Screener
PTC Therapeutics PTCT Balance Sheet Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $508.89M-24.3% | $1.05B+3.2% | $833.99M-43.7% | $984.65M+26.3% | $672.62M+27.9% | ||
| $1.62B+59.5% | $1.18B+21.3% | $1.06B+93.5% | $960.72M+167% | $1.02B+108% | ||
| $238.07M+17.2% | $239.04M+21.9% | $219.92M+4.5% | $181.62M+14.5% | $203.07M+1.5% | ||
| $109.33M+108% | $91.35M+168% | $75.57M+249% | $79.65M+243% | $52.69M+47.7% | ||
| $2.54B+26.4% | $2.62B+15.2% | $2.25B-2.7% | $2.27B+66.5% | $2.01B+56.7% | ||
| $49.33M-13.4% | $51.49M-10.0% | $52.74M-11.3% | $55.37M-9.2% | $56.97M-9.8% | ||
| $82.34M0.0% | $82.34M0.0% | $82.34M0.0% | $82.34M0.0% | $82.34M0.0% | ||
| $443.69M+11.9% | $402.93M+180% | $380.68M+221% | $388.75M+227% | $396.47M+20.0% | ||
| $3.21B+21.3% | $3.25B+23.4% | $2.87B+8.0% | $2.9B+70.0% | $2.64B+43.5% | ||
| $440.81M+45.4% | $382.25M+12.8% | $313.05M-1.5% | $381.27M+25.3% | $303.14M-9.9% | ||
| $1.98M+16.8% | $1.19M-87.8% | $498K-96.1% | $2.04M-62.9% | $1.69M— | ||
| —— | $55.45M+935% | $286.94M+5,585% | $286.63M+9,454% | $286.32M+10,737% | ||
| $776.08M-10.4% | $771.07M+22.8% | $923.6M+55.1% | $968.43M+66.7% | $866.25M+41.8% | ||
| $3.4B+21.4% | $3.42B+20.2% | $3.05B+7.3% | $3.1B+10.7% | $2.8B-3.4% | ||
| $82K+3.8% | $82K+5.1% | $81K+3.8% | $80K+3.9% | $79K+3.9% | ||
| -$2.94B-3.7% | -$2.88B-1.3% | -$2.97B-6.7% | -$2.96B+18.7% | -$2.83B+21.0% | ||
| -$191.21M-22.8% | -$165.36M+19.9% | -$180.47M+2.9% | -$205.31M+81.3% | -$155.76M+85.2% | ||
| $3.21B+21.3% | $3.25B+23.4% | $2.87B+8.0% | $2.9B+70.0% | $2.64B+43.5% |
FAQ
- What are PTC Therapeutics's total assets?
- PTC Therapeutics (PTCT) holds $3.2B in total assets, up 21.3% year over year.
- How much debt does PTC Therapeutics have?
- PTC Therapeutics carries $636.0M in total debt against -$191.2M of shareholders' equity, a debt-to-equity ratio of 372.31.
- How much cash does PTC Therapeutics have?
- PTC Therapeutics holds $508.9M in cash and equivalents.
- Can PTC Therapeutics cover its short-term obligations?
- Its current ratio is 3.27 — current assets exceed current liabilities.
- Where does PTC Therapeutics's balance sheet data come from?
- Every line is extracted from PTC Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
